300636 同和药业
已收盘 04-30 15:00:00
资讯
新帖
简况
同和药业:中泰证券、新华资产等多家机构于4月26日调研我司
证券之星 · 04-29
同和药业:中泰证券、新华资产等多家机构于4月26日调研我司
同和药业(300636)3月31日股东户数1.46万户,较上期增加7.72%
证券之星 · 04-25
同和药业(300636)3月31日股东户数1.46万户,较上期增加7.72%
同和药业最新公告:一季度净利润同比增长31.62%
证券之星 · 04-24
同和药业最新公告:一季度净利润同比增长31.62%
同和药业(300636.SZ)发2023年度业绩,净利润1.06亿元,同比增长5.28%
智通财经 · 04-24
同和药业(300636.SZ)发2023年度业绩,净利润1.06亿元,同比增长5.28%
同和药业(300636.SZ)发一季度业绩,净利润4356.28万元,同比增长31.62%
智通财经 · 04-24
同和药业(300636.SZ)发一季度业绩,净利润4356.28万元,同比增长31.62%
同和药业(300636)4月23日主力资金净买入974.32万元
证券之星 · 04-23
同和药业(300636)4月23日主力资金净买入974.32万元
同和药业1月29日现1笔大宗交易 成交金额314.13万元
智能小浪 · 01-29
同和药业1月29日现1笔大宗交易 成交金额314.13万元
加载更多
公司概况
公司名称:
江西同和药业股份有限公司
所属行业:
医药制造业
上市日期:
2017-03-31
主营业务:
江西同和药业股份有限公司主营业务为化学原料药和医药中间体的研发、生产和销售,主要产品方向为特色化学原料药及中间体、专利原料药中间体。公司是技术驱动型企业,连续多年研发投入占销售额的比例保持在8%-9%,多次被认定为高新技术企业,先后获批组建了“江西省特色原料药工程技术研究中心”、“国家博士后科研工作站”、“江西省企业技术中心”、“江西省博士后创新实践基地”、“江西省新药研发产教融合创新中心”等技术创新平台,具有强大的研发能力和技术创新能力。
发行价格:
14.47
{"stockData":{"symbol":"300636","market":"SZ","secType":"STK","nameCN":"同和药业","latestPrice":10.74,"timestamp":1714460598000,"preClose":10.25,"halted":0,"volume":10059157,"delay":0,"floatShares":364000000,"shares":423000000,"eps":0.2753,"marketStatus":"已收盘","marketStatusCode":5,"change":0.49,"latestTime":"04-30 15:00:00","open":10.25,"high":10.99,"low":10.19,"amount":108000000,"amplitude":0.078,"askPrice":10.74,"askSize":601,"bidPrice":10.73,"bidSize":268,"shortable":0,"etf":0,"ttmEps":0.2753,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":10.25,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":11.28,"lowLimit":9.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":423136145,"pbRate":1.91,"roa":"--","roe":"1.94%","epsLYR":0.2786,"committee":-0.430137,"marketValue":4544000000,"floatMarketCap":3914000000,"peRate":39.011987,"changeRate":0.0478,"turnoverRate":0.0276,"status":0},"requestUrl":"/m/hq/s/300636/","defaultTab":"news","newsList":[{"id":"2431060567","title":"同和药业:中泰证券、新华资产等多家机构于4月26日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2431060567","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431060567?lang=zh_cn&edition=full","pubTime":"2024-04-29 00:05","pubTimestamp":1714320324,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年4月28日同和药业发布公告称中泰证券祝嘉琦、新华资产刘婷、华宝基金张金涛、安信基金池陈森、鹏华基金邱成岳于2024年4月26日调研我司。同和药业主营业务:化学原料药和医药中间体的研发、生产和销售。同和药业2024年一季报显示,公司主营收入2.06亿元,同比下降6.47%;归母净利润4356.28万元,同比上升31.62%;扣非净利润4048.76万元,同比上升23.31%;负债率33.01%,财务费用-556.79万元,毛利率36.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900000037.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430476645","title":"同和药业(300636)3月31日股东户数1.46万户,较上期增加7.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430476645","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430476645?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:18","pubTimestamp":1714036719,"startTime":"0","endTime":"0","summary":"证券之星消息,近日同和药业披露,截至2024年3月31日公司股东户数为1.46万户,较12月31日增加1050.0户,增幅为7.72%。在化学制药行业个股中,同和药业股东户数低于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.33万户。从股价来看,2023年12月31日至2024年3月31日,同和药业区间跌幅为29.41%,在此期间股东户数增加1050.0户,增幅为7.72%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500036037.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429451324","title":"同和药业最新公告:一季度净利润同比增长31.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429451324","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429451324?lang=zh_cn&edition=full","pubTime":"2024-04-24 21:51","pubTimestamp":1713966662,"startTime":"0","endTime":"0","summary":"同和药业公布2024年一季度报告,报告期营业收入2.06亿元,同比下降6.47%;归属于上市公司股东的净利润4356.28万元,同比增长31.62%;基本每股收益0.1037元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400046188.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429455971","title":"同和药业(300636.SZ)发2023年度业绩,净利润1.06亿元,同比增长5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429455971","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429455971?lang=zh_cn&edition=full","pubTime":"2024-04-24 21:11","pubTimestamp":1713964283,"startTime":"0","endTime":"0","summary":"智通财经APP讯,同和药业(300636.SZ)发布2023年年度报告,营业收入7.22亿元,同比增长0.31%。归属于上市公司股东的净利润1.06亿元,同比增长5.28%。归属于上市公司股东的扣除非经常性损益的净利润9813.92万元,同比增长0.76%。基本每股收益0.2786元,向全体股东每10股派发现金红利0.4元(含税),送红股0股(含税),以资本公积金向全体股东每10股转增0股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109181.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429245537","title":"同和药业(300636.SZ)发一季度业绩,净利润4356.28万元,同比增长31.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429245537","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429245537?lang=zh_cn&edition=full","pubTime":"2024-04-24 21:07","pubTimestamp":1713964053,"startTime":"0","endTime":"0","summary":"智通财经APP讯,同和药业(300636.SZ)发布2024年第一季度报告,营业收入2.06亿元,同比减少6.47%。归属于上市公司股东的净利润4356.28万元,同比增长31.62%。归属于上市公司股东的扣除非经常性损益的净利润4048.76万元,同比增长23.31%。基本每股收益0.1037元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109174.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429541501","title":"同和药业(300636)4月23日主力资金净买入974.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429541501","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429541501?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:30","pubTimestamp":1713857459,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月23日收盘,同和药业报收于10.02元,下跌2.62%,换手率3.42%,成交量12.45万手,成交额1.25亿元。4月23日的资金流向数据方面,主力资金净流入974.32万元,占总成交额7.81%,游资资金净流出806.1万元,占总成交额6.46%,散户资金净流出168.22万元,占总成交额1.35%。同和药业主营业务:化学原料药和医药中间体的研发、生产和销售。该股最近90天内共有5家机构给出评级,买入评级3家,增持评级2家;过去90天内机构目标均价为12.3。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300023728.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2407330832","title":"同和药业1月29日现1笔大宗交易 成交金额314.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407330832","media":"智能小浪","top":-1,"share":"https://www.laohu8.com/m/news/2407330832?lang=zh_cn&edition=full","pubTime":"2024-01-29 17:00","pubTimestamp":1706518800,"startTime":"0","endTime":"0","summary":" 1月29日,同和药业收跌9.83%,收盘价为8.07元,发生1笔大宗交易,合计成交量38.93万股,成交金额314.13万元。 第1笔成交价格为8.07元,成交38.93万股,成交金额314.13万元,溢价率为0.00%,买方营业部为机构专用,卖方营业部为机构专用。 进一步统计,近3个月内该股累计发生1笔大宗交易,合计成交金额为314.13万元。该股近5个交易日累计下跌6.81%,主力资金合计净流出1187.64万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-01-29/doc-inafeuwa3646902.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-01-29/doc-inafeuwa3646902.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-03-31","address":"江西省宜春市奉新县江西奉新高新技术产业园区","stockEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":0.4435},{"period":"3month","weight":0.5063},{"period":"6month","weight":-0.0612},{"period":"1year","weight":-0.2023},{"period":"ytd","weight":0.019}],"companyName":"江西同和药业股份有限公司","boardCode":"AI0027","perCapita":"24878股","boardName":"医药制造业","registeredCapital":"42313万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 江西同和药业股份有限公司主营业务为化学原料药和医药中间体的研发、生产和销售,主要产品方向为特色化学原料药及中间体、专利原料药中间体。公司是技术驱动型企业,连续多年研发投入占销售额的比例保持在8%-9%,多次被认定为高新技术企业,先后获批组建了“江西省特色原料药工程技术研究中心”、“国家博士后科研工作站”、“江西省企业技术中心”、“江西省博士后创新实践基地”、“江西省新药研发产教融合创新中心”等技术创新平台,具有强大的研发能力和技术创新能力。","serverTime":1714659260243,"listedPrice":14.47,"stockholders":"14649人(较上一季度增加7.72%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同和药业(300636)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同和药业(300636)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同和药业,300636,同和药业股票,同和药业股票老虎,同和药业股票老虎国际,同和药业行情,同和药业股票行情,同和药业股价,同和药业股市,同和药业股票价格,同和药业股票交易,同和药业股票购买,同和药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同和药业(300636)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同和药业(300636)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}